PMID- 24576550 OWN - NLM STAT- MEDLINE DCOM- 20141125 LR - 20140401 IS - 1873-3913 (Electronic) IS - 0898-6568 (Linking) VI - 26 IP - 6 DP - 2014 Jun TI - The eIF2B-interacting domain of RGS2 protects against GPCR agonist-induced hypertrophy in neonatal rat cardiomyocytes. PG - 1226-34 LID - S0898-6568(14)00066-7 [pii] LID - 10.1016/j.cellsig.2014.02.006 [doi] AB - The protective effect of Regulator of G protein Signaling 2 (RGS2) in cardiac hypertrophy is thought to occur through its ability to inhibit the chronic GPCR signaling that promotes pathogenic growth both in vivo and in cultured cardiomyocytes. However, RGS2 is known to have additional functions beyond its activity as a GTPase accelerating protein, such as the ability to bind to eukaryotic initiation factor, eIF2B, and inhibit protein synthesis. The RGS2 eIF2B-interacting domain (RGS2(eb)) was examined for its ability to regulate hypertrophy in neonatal ventricular myocytes. Both full-length RGS2 and RGS2(eb) were able to inhibit agonist-induced cardiomyocyte hypertrophy, but RGS2(eb) had no effect on receptor-mediated inositol phosphate production, cAMP production, or ERK 1/2 activation. These results suggest that the protective effects of RGS2 in cardiac hypertrophy may derive at least in part from its ability to govern protein synthesis. CI - Copyright (c) 2014 Elsevier Inc. All rights reserved. FAU - Chidiac, Peter AU - Chidiac P AD - Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON N6A 5C1, Canada. FAU - Sobiesiak, Alina J AU - Sobiesiak AJ AD - Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON N6A 5C1, Canada. FAU - Lee, Katherine N AU - Lee KN AD - Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON N6A 5C1, Canada. FAU - Gros, Robert AU - Gros R AD - Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON N6A 5C1, Canada. FAU - Nguyen, Chau H AU - Nguyen CH AD - Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON N6A 5C1, Canada; School of Pharmacy, D'Youville College, Buffalo, NY 14201, USA. Electronic address: nguyenc@dyc.edu. LA - eng GR - Canadian Institutes of Health Research/Canada PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20140224 PL - England TA - Cell Signal JT - Cellular signalling JID - 8904683 RN - 0 (Eukaryotic Initiation Factor-2B) RN - 0 (Inositol Phosphates) RN - 0 (RGS Proteins) RN - 0 (RGS2 protein, rat) RN - 0 (Receptors, G-Protein-Coupled) RN - 1WS297W6MV (Phenylephrine) RN - E0399OZS9N (Cyclic AMP) RN - L628TT009W (Isoproterenol) SB - IM MH - Animals MH - Animals, Newborn MH - Cardiomegaly/*metabolism MH - Cell Size/drug effects MH - Cells, Cultured MH - Cyclic AMP/metabolism MH - Eukaryotic Initiation Factor-2B MH - Gene Expression MH - Inositol Phosphates/metabolism MH - Isoproterenol/pharmacology MH - Myocytes, Cardiac/drug effects/*metabolism/pathology MH - Phenylephrine/pharmacology MH - Protein Biosynthesis MH - Protein Interaction Domains and Motifs MH - RGS Proteins/chemistry/*physiology MH - Rats MH - Receptors, G-Protein-Coupled/*agonists/physiology MH - Second Messenger Systems OTO - NOTNLM OT - Cardiac hypertrophy OT - G protein OT - GPCR OT - Protein synthesis OT - RGS protein EDAT- 2014/03/01 06:00 MHDA- 2014/12/15 06:00 CRDT- 2014/03/01 06:00 PHST- 2013/08/27 00:00 [received] PHST- 2014/02/05 00:00 [revised] PHST- 2014/02/11 00:00 [accepted] PHST- 2014/03/01 06:00 [entrez] PHST- 2014/03/01 06:00 [pubmed] PHST- 2014/12/15 06:00 [medline] AID - S0898-6568(14)00066-7 [pii] AID - 10.1016/j.cellsig.2014.02.006 [doi] PST - ppublish SO - Cell Signal. 2014 Jun;26(6):1226-34. doi: 10.1016/j.cellsig.2014.02.006. Epub 2014 Feb 24.